Le Lézard
Classified in: Science and technology, Business
Subjects: TNM, PER

Cognosante Names Kevin Mostek New Head of Mergers & Acquisitions


FALLS CHURCH, Va., April 15, 2021 /PRNewswire-PRWeb/ -- Cognosante recently appointed Kevin Mostek as the company's new Corporate Development Officer. In this newly created role, Mostek will be responsible for leading the company's Merger and Acquisition (M&A) strategy, reporting directly to the Chief Executive Officer (CEO).

"As the company continues to strengthen its organic growth engine, we are looking to augment our core capabilities and expand into adjacent markets through strategic acquisitions," said Michele Kang, CEO of Cognosante. "Kevin brings a wealth of company and industry knowledge which is critical to this role; having served in various executive leadership roles since 2013, including most recently as the Chief Financial Officer."

"I am excited to assume this new role at a time of such tremendous growth and opportunity for Cognosante. My finance and contracts experience, coupled with my participation in previous Cognosante-related M&A transactions, positions me well to develop creative approaches to continue to expand our market share across Federal and State agencies," said Mostek.

Kevin Mostek holds a Master of Science in Engineering from Purdue University and a Bachelor of Science in Engineering from Lehigh University.

About Cognosante
Cognosante is a mission-driven technology company that delivers innovative and transformative solutions to improve the health and safety of Americans. The company has more than a decade of experience working with States and the Federal government to improve access to care, advance clinical performance, and outcome, protect from disasters and pandemics, and address the social determinants of health by developing, managing, and executing large multi-faceted technology and BPO solutions. Its expertise includes Medicaid, Medicare, military and Veterans' health, the health insurance marketplace, data standards and analytics, cybersecurity, biometrics, State health exchanges, and modular system development and integration.

Media Contact

Cydney Peyton Walton, Cognosante, 571.367.7270, [email protected]

 

SOURCE Cognosante


These press releases may also interest you

at 09:28
IDTechEx Research, a trusted provider of independent market intelligence, announces the availability of a new report, "Thermal Energy Storage 2024-2034: Technologies, Players, Markets, and Forecasts"....

at 09:27
Serum Detect, a cancer diagnostics company, is debuting a novel and promising approach for cancer early detection at the...

at 09:25
Veeam® Software, the #1 leader by market share in Data Protection and Ransomware Recovery, today announced that the City of Fort Lauderdale, Florida, has deployed Veeam Data Platform and Veeam Backup for Microsoft 365 to enable high-speed recovery of...

at 09:25
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2023 annual results as of 31 December 2023. Financial Highlights Revenue increased by 18.1% to...

at 09:25
To help prepare nursing students for real-world practice, Wolters Kluwer Health today announces the launch of Lippincott Ready for NCLEX®, a complete test prep solution for the National Council Licensure Examination (NCLEX). The new product marks the...

at 09:22
A unique online platform, My Yoga Journey, has been launched by Yourself Yoga for Menopause to provide yoga exclusively for women in menopause who prefer a natural solution to help alleviate their symptoms....



News published on and distributed by: